Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | -.--% | -.--% | -.--% |
04-19 | Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
03-13 | Joel Dumaresq Resigns as Director of Orion Nutraceuticals Inc | CI |
Business Summary
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guy Bourgeois
CEO | Chief Executive Officer | - | 06/06/23 |
Amanda Boudreau
BRD | Director/Board Member | - | 06/06/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,307,965 | 28,907,965 ( 98.64 %) | 0 | 98.64 % |
Company contact information
Orion Nutraceuticals, Inc.
789 West Pender Street Suite 810
V6C 1H2, Vancouver
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 8.68M | |
+41.06% | 6.19B | |
-15.95% | 4.48B | |
+6.36% | 3.29B | |
-11.34% | 3.12B | |
-3.12% | 2.5B | |
+45.41% | 1.94B | |
-7.74% | 1.68B | |
-0.67% | 1.64B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- ORI Stock
- Company Orion Nutraceuticals Inc.